Today: 21 July 2026
Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move
28 January 2026
1 min read

Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move

New York, Jan 28, 2026, 11:37 EST — Regular session

Lam Research shares slipped 0.1% to $238.15 by 11:37 a.m. EST, retreating from an early gain and edging toward session lows ahead of the chip equipment maker’s quarterly report scheduled after the bell.

The setup is straightforward but tense. Chip-tool makers are benefiting from a surge in AI-driven spending, yet their fate hinges on customer guidance about factory plans over the coming quarters.

Options traders are pricing in a big move. According to TipRanks, implied volatility suggests Lam’s stock could swing roughly 7.9% up or down after the earnings report, reflecting sharp expected market reactions.

Analysts surveyed by Seeking Alpha forecast Lam will report earnings of $1.17 per share on roughly $5.24 billion in revenue.

Lam will conduct its December 2025 earnings call this Wednesday at 2:00 p.m. Pacific, the company’s investor relations page shows.

Mizuho boosted its price target on Lam from $220 to $265 in a bullish note ahead of earnings. The broker projects wafer fab equipment (WFE) spending—the gear used to build and expand chip factories—will climb 13% in 2026 and 12% in 2027, describing the growth as a “significant acceleration.” TipRanks

Chip stocks have found support as the broader market pushes higher. The S&P 500 surpassed the 7,000 mark on Wednesday, buoyed by semiconductor gains ahead of the U.S. Federal Reserve’s rate decision, Reuters noted. “These big round numbers can be difficult psychological tests for the market,” said Jeff Buchbinder, chief equity strategist at LPL Financial. Reuters

Applied Materials climbed 1.2% in chip-equipment stocks, with KLA adding 0.3%. Meanwhile, ASML’s shares listed in the U.S. dipped 1.9%. The VanEck Semiconductor ETF moved higher by roughly 1.9%.

Investors are watching closely for shifts in tone on foundry and memory demand, the speed of new tool orders, and the split between Lam’s growth from recurring services versus new systems. Often, the guidance carries more weight than the quarter’s raw numbers.

The stock has hit the print with expectations already high. Even a slight sign of customers putting off factory spending, or pressure on margins, could quickly drag shares down — notably since the options market points to a potentially sharp move.

The company’s results arrive after the U.S. close on Jan. 28, with a keen focus on management’s outlook for the spending cycle through 2026.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Centerra Gold Places 44th on Metals Channel Global Mining Titans Index in Analyst Ratings
    July 21, 2026, 12:19 PM EDT. Centerra Gold Inc (CGAU) holds the 44th position among 50 stocks in the Metals Channel Global Mining Titans Index, ranked according to the consensus of major brokerage analyst recommendations. The index features leading global metals and mining firms and tracks shifts in commodity prices and market dynamics. CGAU operates within the Precious Metals sector, alongside peers such as Newmont Corp (NEM) and Barrick Mining Corp (B). Shares of CGAU rose about 4.5% by midday Tuesday.
ASML stock price rises in premarket after orders beat, 2026 outlook raised, job cuts flagged
Previous Story

ASML stock price rises in premarket after orders beat, 2026 outlook raised, job cuts flagged

Eli Lilly stock drops today: LLY slides after $1.12 billion gene-editing deal and Medicare pricing signal
Next Story

Eli Lilly stock drops today: LLY slides after $1.12 billion gene-editing deal and Medicare pricing signal

Go toTop